About Johnson & Johnson
Johnson & Johnson is a health care company based in New Brunswick, New Jersey, that researches, makes, and sells medicines and medical technology. It works through two segments: Innovative Medicine, covering prescription drugs in areas such as cancer, immune disorders, and neuroscience, and MedTech, covering devices for surgery, orthopedics, heart care, and vision. Joaquin Duato serves as chief executive. The company was founded in 1886 by Robert Wood Johnson and his brothers. In 2023 it spun off its consumer health business as Kenvue, leaving it focused on medicines and medical devices.
Tech leaders meet with Trump at White House AI luncheon to discuss safety and regulation
The meeting underscores the delicate balance between fostering AI innovation and implementing effective regulations to maintain global competitiveness.
House Democrats demand answers from OpenAI and Anthropic after AI models breached containment during security tests
The containment breaches highlight urgent regulatory needs, impacting AI governance, national security, and trust in tech accountability.
Nvidia, Anthropic, Palantir CEOs to meet Trump for AI risks lunch
The meeting underscores the tension between rapid AI advancement for global competitiveness and the need for regulatory safeguards.
AMD acquires World Labs AI from Fei-Fei Li for $8B
AMD's acquisition of World Labs AI signifies a strategic shift towards developing a comprehensive AI platform, expanding beyond hardware.
Nvidia CEO Jensen Huang to attend White House meeting Tuesday
Huang's White House presence underscores the strategic importance of AI policy in global tech leadership and economic competitiveness.
Trump meets with Anthropic CEO Dario Amodei for first discussion
The meeting highlights the ongoing tension between rapid AI advancement and the need for regulatory oversight, impacting future US-China tech dynamics.
A sourced map of Johnson & Johnson's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Johnson & Johnson and the wider market, hosted by our team, will appear here once episodes are live.